繁體
简体中文
繁體中文

Syneos Health, Inc. Class A SYNH

已收盤 09-28 16:00:00 美东时间

42.98

0.000

0.00%

华盛通華盛通
立即下載
  • 最 高--
  • 今 開--
  • 成交量 0股
  • 最 低 --
  • 昨 收 42.98
  • 總市值 446.99万
  • 52周最高 52.23
  • 市盈率 16.69
  • 換手率 0.00%
  • 52周最低 22.894
  • 委 比 0.00%
  • 總股本 0.00亿
  • 歷史最高 104.18
  • 量 比 0
  • 振 幅 0.00%
  • 歷史最低 22.894
  • 每 手 1
  • 風險率 0.00%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer

    Pyxis Oncology appoints Nelson Azoulay as Chief Business Officer. With over 15 years of experience in corporate strategy and biopharma transactions, Azoulay will lead corporate development and advance MICVO, the company's lead ADC targeting EDB+FN in solid tumors. MICVO is in Phase 1/2 trials for recurrent/metastatic head and neck cancer and has received FDA Fast Track Designation. Azoulay's expertise in ADCs and strategic transactions is expecte...

    05-07 20:05

  • Telix Appoints David Gill as Non-Executive Director

    <p>Telix Pharmaceuticals Limited has appointed David Gill as a Non-Executive Director, effective May 11, 2026, with plans for him to become Chair in the future. Mr. Gill, a seasoned executive with over 35 years of experience in finance and leadership roles, brings expertise in capital markets, business scaling, and corporate strategy. Telix, a global biopharmaceutical company focused on radiopharmaceuticals, aims to strengthen its board as it con...

    04-01 23:53

  • Syneos Health’s COGNIKET-MCI Trial: A Promising Step in Cognitive Health Research

    Syneos Health (($SYNH)) announced an update on their ongoing clinical study. St...

    2025-08-15 00:21

  • CytoDyn Phase 2 study of leronlimab cleared by FDA

    CytoDyn (OTCQB:CYDY) said the FDA has cleared a Phase 2 study of its drug leronlimab for the treatment of relapsed/refractory microsatellite stable colorectal cancer. Patient enrollment for the study ...

    2024-11-04 23:22

  • 疫情红利殆尽后 华尔街仍看好CRO未来机遇

    华尔街分析师和Seeking Alpha的撰稿人认为CRO领域存在买入机会。

    2023-07-03 09:43

  • SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTIC, LTHM, SYNH, FRG

    NEW YORK, May 10, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...

    2023-05-11 00:17

  • 盘前:道指期货跌0.2% 美国4月CPI数据即将揭晓

      美股股指期货周三盘前涨跌互现,美国消费者物价指数将于今日公布,可能影响今年降息的预期。与此同时,美国总统拜登未能在债务上限问题上打破僵局,亦打压市场。  ...

    2023-05-10 20:26

  • Syneos Health: Q1 Earnings Insights

    Syneos Health (NASDAQ:SYNH) reported its Q1 earnings results on Wednesday, May ...

    2023-05-10 19:15